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Abstract 
Metallohydrolases catalyse some of the most important reactions in biology 
and are targets for numerous chemotherapeutic agents designed to combat 
bacterial infectivity, antibiotic resistance, HIV infectivity, tumour growth, 
angiogenesis and immune disorders. Rational design of inhibitors of these 
enzymes with chemotherapeutic potential relies on detailed knowledge of the 
catalytic mechanism. The roles of the catalytic transition ions in these 
enzymes have long been assumed to include the activation and delivery of a 
nucleophilic hydroxy moiety. In the present study, catalytic intermediates in 
the hydrolysis of L-leucyl-L-leucyl-L-leucine by Vibrio proteolyticus 
aminopeptidase were characterized in spectrokinetic and structural studies. 
Rapid-freeze-quench EPR studies of reaction products of L-leucyl-L-leucyl-L-
leucine and Co(II)-substituted aminopeptidase, and comparison of the EPR 
data with those from structurally characterized complexes of aminopeptidase 
with inhibitors, indicated the formation of a catalytically competent post-
Michaelis pre-transition state intermediate with a structure analogous to that 
of the inhibited complex with bestatin. The X-ray crystal structure of an 
aminopeptidase–L-leucyl-L-leucyl-L-leucine complex was also analogous to 
that of the bestatin complex. In these structures, no water/hydroxy group 
was observed bound to the essential metal ion. However, a water/hydroxy 
group was clearly identified that was bound to the metal-ligating oxygen atom 
of Glu152. This water/hydroxy group is proposed as a candidate for the active 
nucleophile in a novel metallohydrolase mechanism that shares features of 
the catalytic mechanisms of aspartic proteases and of B2 metallo-β-
lactamases. Preliminary studies on site-directed variants are consistent with 
the proposal. Other features of the structure suggest roles for the dinuclear 
centre in geometrically and electrophilically activating the substrate. 
Keywords: aminopeptidase, cobalt, EPR, metallohydrolase, Vibrio 
proteolyticus, zinc 
 
Abbreviations: BuBA, 1-butaneboronic acid; LL, L-leucyl-L-leucine; LLL, L-
leucyl-L-leucyl-L-leucine; LPA, L-leucine phosphonic acid; LPNA, L-leucine-p-
nitroanilide; PSMA, prostate-specific membrane antigen; RFQ, rapid-freeze-
quench; VpAP, aminopeptidase from Vibrio proteolyticus 
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Introduction 
The aminopeptidase from the bacterium Vibrio proteolyticus 
(VpAP) is one of the more intensively studied metalloaminopeptidases 
[1,2]. Metalloaminopeptidases are key players in cellular targeting of 
proteins and protein degradation [3,4], aging [5], cataract formation 
[6], HIV infectivity [7], bacterial infectivity [8], angiogenesis [9,10] 
and cancer [9,11]. VpAP itself is of significant biomedical interest on 
two accounts. First, aminopeptidases that are almost identical with 
VpAP and are secreted by pathogenic bacteria that include species of 
Vibrio, Aeromonas, Streptomyces and Clostridium have been shown to 
be virulence factors in infectivity [8,12,13]. Aeromonad and non-
choleraic vibrioid infections are an emerging public health concern, 
giving rise to meningitis, osteomyelitis (bone infection), endocarditis 
(infection of the lining and valves of the heart), wound infection and, 
particularly, gastroenteritis [14–17]. Many of these bacteria have now 
been found to have developed resistance to both traditional and ‘third-
generation’ antibiotics [18], but appear to be sensitive to 
metalloaminopeptidase inhibitors [19]. VpAP inhibitors are therefore 
possible candidates or templates for antibacterial drugs. A second 
reason for interest in VpAP is the association of leucine 
aminopeptidase activity with some cancers and the antitumour efficacy 
of some potent VpAP inhibitors [7,20]. In addition, a THREADER [21] 
analysis predicted that VpAP would have a strong (P=1) structural 
homology with the carboxypeptidatic domain of the PSMA (prostate-
specific membrane antigen); this has been confirmed following 
crystallographic characterization of the PSMA ectodomain, and the 
dimetallic active sites of these enzymes are superimposable [22]. Thus 
mechanistic information on VpAP may well be relevant to PSMA and 
other peptidases involved in cancer. 
Native VpAP contains a (μ-aquo)(μ-carboxylato)-bridged dizinc 
active site [23]. Zn(II) can be site-specifically replaced in either the 
first (‘M1’) or second (‘M2’) site by many other transition ions, and 
Co(II) furnishes monometallic [Co_(VpAP)], homodimetallic 
[CoCo(VpAP)] and heterodimetallic [CoZn(VpAP)] and [ZnCo(VpAP)] 
forms of the enzyme that, functionally, closely resemble the native 
zinc-containing enzyme [24–26]. A combination of EPR spectroscopy 
of Co(II)-containing VpAP and X-ray crystallography has been used to 
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characterize the resting state, an inhibited species corresponding to a 
putative Michaelis complex analogue, and a transition state analogue 
complex of the enzyme [24,25,27–31]. Kinetic studies have provided 
further mechanistic insight [26,32]. A detailed mechanism has been 
proposed on the basis of these studies and was presented in graphic 
form as Figure 10 in the original description by Petsko, Holz and co-
workers [31]. The mechanism invokes (i) binding of substrate to a 
substrate-recognition site distinct from the metal-containing active 
site, (ii) binding of the carbonyl oxygen of the substrate to the M1 
metal ion, with concomitant terminalization of the hitherto bridging 
water molecule, providing an activated nucleophilic hydroxy group, 
also bound to M1, (iii) nucleophilic attack of the M1-bound nucleophile 
at the carbonyl carbon atom, forming a tetrahedral transition state, 
and (iv) collapse of the transition state and proton transfer from 
Glu151, yielding product and resting enzyme. Consistent with this 
proposed mechanism, M1 is essential for catalysis. In contrast, the 
effect of the presence of the second, M2, metal ion on catalytic 
parameters is complex and is dependent on the nature of both M1 and 
M2. EPR and crystallographic studies with the transition-state analogue 
inhibitor LPA (L-leucine phosphonic acid) have characterized strong 
interactions between LPA and the M2 metal ion, and M2 was proposed 
to function to stabilize the transition state. Thus the primary function 
of M1 has been described as providing the hydrolytic nucleophile for 
attack on the M1-immobilized substrate, whereas that of M2 is to 
stabilize the transition state. 
In order to obtain further information on the hydrolytic 
mechanism of VpAP, we carried out EPR spectrokinetic and X-ray 
crystallographic studies of the enzyme using the bona fide substrate 
LLL (L-leucyl-L-leucyl-L-leucine). While the proposed mechanism for 
VpAP is consistent with a substantial body of experimental work, other 
observations do not sit well with it. The complex substrate specificity 
of VpAP and very closely related enzymes [33–37], the reaction 
specificity, and the unusual and complex pattern of activation by 
transition ions [26,38] are not explained by the proposed roles of M1 
in the exposed active site of VpAP. The difficulty of reconciling these 
and other observations with the proposed hydrolytic mechanism of 
VpAP prompted a reexamination of the mechanism. For the first time, 
direct structural information on the reaction of bona fide substrates 
with VpAP was sought. In the present work, we describe the EPR 
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spectra of catalytic intermediate species generated by RFQ (rapid-
freeze-quench) techniques and the X-ray crystallographic structure of 
VpAP in complex with the substrate LLL. Comparison of the EPR and 
structural data with X-ray crystallographic structures and EPR data 
from VpAP complexes with the inhibitors bestatin {ubenimex; N-
[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butyryl]-L-leucine} and 
amastatin {(2S,3R)-3-amino-2-hydroxy-5-methylhexanoyl-Val-Val-
Asp-OH} indicate that the active site of the VpAP–LLL complex 
characterized by X-ray crystallography corresponds to a catalytically 
competent species in solution and observed in the RFQ–EPR studies. 
On the basis of these data, a hitherto unconsidered novel mechanism 
is proposed for the N-terminal hydrolysis of LLL by VpAP. The 
proposed mechanism contains aspects of those of aspartic proteases 
and class II aldolases, and of the mechanism recently proposed for the 
class B2 metallo-β-lactamases on the basis of computational studies 
[39]. This mechanism may represent a new paradigm for 
metalloenzyme-catalysed hydrolysis in what could be considered a 
distinct class of metallohydrolases, one in which the hydrolytically 
active nucleophile is not delivered to the substrate by the metal ion(s). 
Experimental 
General chemicals 
Except where stated, all reagents were of ACS or equivalent 
quality. Milli-Q purified water (Millipore) was used throughout. Sea 
salt, for culture of V. proteolyticus, was obtained from Sigma–Aldrich. 
2-Methylbutane (isopentane) used for RFQ was certified ≥95% grade 
from Fisher. 
VpAP preparation 
VpAP was purified from the supernatant of a 10 litre fermenter 
(BioFlo) culture of V. proteolyticus (obtained from Professor R.C. Holz, 
Department of Chemistry and Biochemistry, Utah State University, 
Logan, UT, U.S.A.) as described in previous work [24]. VpAP was 
characterized by electronic absorption spectrophotometry [40], 
hydrolytic activity towards LPNA (L-leucine-p-nitroanilide) [26], 
SDS/PAGE (12% gels) [41] and the Bio-Rad protein-binding dye assay 
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[42] using well-characterized samples of purified VpAP as standards. 
VpAP thus characterized was found to be >95% pure by SDS/PAGE 
(12% gels), with specific activity indistinguishable from earlier 
preparations. ApoVpAP was prepared by dialysis against 1,10-
phenanthroline for 72 h at 4 °C, followed by exhaustive dialysis 
against Chelex™-treated buffer (50 mM Hepes, pH 7.2). [Co_(VpAP)] 
was prepared by the addition of 1 equiv. of CoCl2, and [CoZn(VpAP)] 
was prepared by incubation with 0.9 equiv. of CoCl2 for 10 min at 
25 °C, followed by addition of 1.1 equiv. of ZnCl2. 
Site-directed variants of VpAP 
Recombinant wild-type and site-directed variants of VpAP were 
generated using the expression system of Bzymek and Holz [32] and 
Bzymek et al. [43]. Expression was induced in cell cultures exhibiting a 
D600 of ∼0.9 with 1 mM IPTG (isopropyl β-D-thiogalactoside) and the 
cultures were incubated further at 30 °C for 5.5 h with agitation in air 
at 250 rev./min. Supernatant was clarified by centrifugation at 6500 g 
for 10 min, and VpAP was precipitated with 560 g/l (NH4)2SO4. The 
precipitate was pelleted at 10500 g for 1 h, redissolved in 50 mM 
Hepes buffer, pH 7.5, dialysed against Hepes buffer, treated with 
proteinase K and heat-treated for 2 h at 70 °C to denature 
contaminating proteins and to process the translated polypeptide to 
the mature enzyme form [43]. 
Kinetic studies 
Hydrolysis of LPNA, LL (L-leucyl-L-leucine) and LLL was 
monitored spectrophotometrically at 405 and 220 nm respectively 
using an Applied Photophysics Model SX.18MV stopped-flow 
instrument at 2–40 °C. LLL, LL or LPNA (2.5 mM final concentration) 
was reacted with VpAP (27.5 μM final concentration) in 10 mM Tricine 
buffer, pH 8.0. Apparent kinetic parameters K′m and k′cat for hydrolysis 
of LLL to LL, LL to leucine, and LPNA to leucine and p-nitroanilide 
under these conditions were estimated by fitting the appropriate part 
of the progress curve that exhibited a linear relationship between 
t−1{ln([S0]/[St])} and t−1([S0]−[St]) [44]. 
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RFQ–EPR studies 
RFQ was carried out using the apparatus described in detail and 
calibrated as in previous studies [45]. LLL (2.5 mM final concentration) 
was reacted with 0.5 mM (final concentration) [CoZn(VpAP)] for 
10 ms–1 s at 2 °C. A sample was thawed and refrozen and was 
estimated to have been incubated for 1 min. [CoZn(VpAP)] has been 
reported to exhibit a pH-dependent mixture of EPR signals, a rhombic 
signal with 59Co hyperfine splitting and an axial signal devoid of 
hyperfine structure [24,25]. It was observed that this form of VpAP 
exhibited an essentially pure rhombic signal following incubation with 
substrate (LPNA or LLL) and recovery by dialysis, and this form of the 
enzyme was used as the starting material for RFQ–EPR studies. EPR 
was performed using a Bruker E500 EleXsys spectrometer equipped 
with an ER4116DM TE012/TE021 dual mode cavity operating at 9.63 GHz 
in normal (Bstatic∥Bmicrowave) mode. Temperature control was effected 
using an Oxford Instruments ESR900 helium flow cryostat and ITC502 
temperature controller. Spectra were recorded at 9 K and 2 mW 
microwave power, with 1.06 mT (10.6 G) field modulation at 100 kHz. 
These conditions provided the best signal-to-noise ratio attainable 
without detectable distortion of the spectra due to saturation, 
relaxation broadening or rapid-passage effects. Individual EPR-
detectable species were isolated by difference analysis of spectra of 
resting enzyme and of reaction mixtures trapped at various times. 
Basis spectra were confirmed as single species by computer simulation 
(XSophe, Bruker Biospin [46]). Experimental spectra were modelled, 
and contributions of individual species were quantified, by linear 
combination and double integration respectively, of simulated basis 
spectra. The reference sample for quantification was 0.5 mM Co(II) in 
50 mM Hepes buffer, pH 7.2, and 50% glycerol, recorded under non-
saturating conditions (0.1 mW, 13 K), and the standard corrections for 
gx(eff.)av., 1/T and (microwave power)½ were applied. 
Crystallization of VpAP 
VpAP was crystallized using the sitting-drop method. VpAP 
(0.5 mM) in 10 mM Tris buffer, pH 8.0, containing 10 mM KSCN and 
400 mM NaCl was equilibrated with 100 mM Tris buffer, pH 8.0, 
containing 100 mM KSCN and 4.5 M NaCl; Tris was found to be an 
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essential component. Crystals thus obtained underwent successive 
transfer and incubation in 100 mM Hepes buffer, pH 8.0, containing 
100 mM KSCN and 4.5 M NaCl, in order to remove Tris bound at the 
active site [47]. A single microcrystalline speck of LLL was added, and 
the crystallization plate was incubated at 23 °C for 16 h before data 
collection. 
X-ray crystallography 
Paratone-N (Hampton Research) was used as a cryoprotectant. 
The diffraction data were collected at −160 °C on a Rigaku R-AXIS 
IV++, using Crystal Clear software. One crystal was used to collect the 
entire set of data. An oscillation step size of 0.5° was used to collect 
5.5 min exposures. Data were processed, and unit cell parameters 
were determined with HKL2000 [48]. Since the aminopeptidase crystal 
soaked in LLL was isomorphous with that of aminopeptidase bound to 
BuBA (1-butaneboronic acid), the phases from that structure (PDB 
code 1CP6 [29]) were used to solve the structure by molecular 
replacement using AMoRe [49]. Model building was performed with the 
interactive three-dimensional graphic program, Turbo-Frodo (version 
OpenGL). The structure was manually inspected with electron density 
maps with 2Fobs−Fcalc and Fobs−Fcalc coefficients. Structures were refined 
using iterative cycles of energy minimization using the program 
package CNS1.1 [50], alternating with manual map-fitting and model 
rebuilding. Progress of the refinement was confirmed by the steady 
decrease in both the Rcrystal and Rfree values. Water molecules were 
added to the model using the WATERPICK protocol from CNS1.1. 
Procheck was used to check Ramachandran (Φ, ψ) values [51]. 
Results 
Kinetic studies 
As prepared VpAP, and VpAP redissolved from crystalline 
material, was found to be active towards both LPNA and LLL. A linear 
relationship between ln(k′cat) and 1/T was observed for the hydrolysis 
of LPNA by VpAP between 6 and 65 °C; the activation energy, Ea, was 
estimated as 66 kJ·mol−1 and apparent kinetic constants for LPNA were 
K′m (LPNA)=16 μM (6 °C) and 29 μM (25 °C), and k′cat (LPNA)=13 s−1 
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(6 °C) and 82 s−1 (25 °C). These data extrapolated to a turnover time 
of 83 ms at 2 °C. Apparent kinetic constants for LLL and LL, K′m 
(LLL)=15 μM (6 °C) and 28 μM (25 °C), k′cat (LLL)=1.7 s−1 (6 °C) and 
7 s−1 (25 °C), K′m (LL)=48 μM (6 °C) and 90 μM (25 °C), and k′cat 
(LL)=0.3 s−1 (6 °C) and 2.6 s−1 (25 °C), indicated similar 
thermodynamics for these substrates, although with slightly higher 
values for Ea and, consequently, for the enthalpy of hydrolysis of these 
substrates. Extrapolated turnover times for LLL and LL at 2 °C were 
estimated as 380 ms and 3.6 s respectively. Recombinant wild-type 
VpAP exhibited k′cat (LPNA)=10±3 s−1 (25 °C). Of the site-directed 
variants E152D, E152T, E152S and E152Y, E152D preparations 
exhibited 30–90% of the specific activity of wild-type VpAP, whereas 
the others exhibited no activity under the assay conditions used (<5% 
of wild-type activity). Control preparations from non-transfected cells 
and from non-induced cultures of wild-type and E151D expression 
systems did not exhibit any detectable activity towards LPNA. 
RFQ–EPR studies 
EPR spectra of resting [CoZn(VpAP)] and VpAP reacted with LLL 
for 10 ms, 20 ms, 1 s and 1 min are shown as traces A–E in Figures 1 
and and22 (Figure 2 shows the 59Co hyperfine structure expanded). 
The spectrum of VpAP before reaction consisted of a single species and 
was simulated as a rhombic signal with spin Hamiltonian parameters 
S=3/2, MS=|±½〉, gx,y=2.57, gz=2.24, D≫gβBS (where D≫gβBS, 
spectra are insensitive to D; D=50 cm−1 was used throughout), 
E/D=0.21 and AyI=7/2(59Co)=8.1×10−3 cm−1. This EPR species is termed 
the ‘resting’ species, even where observed in samples other than 
resting enzyme. Upon reaction with LLL, clear changes in the spectrum 
were observed and two new species (traces F and G in Figure 1) were 
isolated from the experimental spectra of Figure 1, traces A, B and C. 
The spectrum of traces F in Figure 1, termed here the ‘LLL-axial’ 
signal, was very broad, no hyperfine structure was resolved, and the 
high-field gz feature was not resolved. The LLL-axial signal was 
consistent with the approximate spin Hamiltonian parameters 
gx,y∼2.28 and E/D∼0 (the parameters used for simulation were S=3/2, 
MS=|±½〉, gx,y=2.28, gz=2.20, D=50 cm−1 and E/D=0.05). The 
second species isolated by difference is shown as traces G in Figure 1 
and is termed the ‘LLL-rhombic’ species; simulation returned the spin 
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Hamiltonian parameters S=3/2, MS=|±½〉, gx,y=2.56, gz=2.50, 
D≫gβBS (50 cm−1), E/D=0.29 and AyI=7/2(59Co)=8.4×10−3 cm−1. Using 
linear combinations of the three basis spectra, the resting, LLL-axial 
and LLL-rhombic signals, the experimental spectra were reconstructed 
as shown in Figures 1 and and2,2, and the proportions of each of the 
basis spectra used in the simulations of the experimental spectra are 
shown in Figure 3. Because the spectra contain both very broad and 
very sharp features, least-squares iterative fitting is not an appropriate 
fitting tool. The relative proportions of the resting and LLL-rhombic 
species were judged both by the overall fit to the spectrum (Figure 1) 
and by the fit of the complex hyperfine pattern at 700–1300 G (Figure 
2), and changes in the values for the contributions of the resting and 
LLL-rhombic of more than 10% of those used for the simulations 
produced computed spectra that clearly did not match the 
experimental data. The simulations were relatively insensitive, 
however, to the inclusion of the LLL-axial species. Subtraction of 
traces A from traces B (Figure 1) clearly showed that the LLL-axial 
signal was present in trace B and integration of the simulation of the 
difference spectrum indicated that it accounted for ∼10% of the spin 
density of the EPR signal after 10 ms. It is unclear whether an axial 
component is present in the spectrum of the resting enzyme or 
whether some residual contribution of an axial signal is present at 
20 ms and beyond, but it is clear that the intensity of the LLL-axial 
signal increases up to 10 ms and diminishes thereafter. An interesting 
observation was that the spin Hamiltonian parameters of the much 
more well-defined LLL-rhombic species were very similar to those 
reported for the EPR signal observed upon the addition of the 
antitumour agent bestatin to [CoZn(VpAP)] [31] and, particularly, 
almost indistinguishable from those obtained [S=3/2, MS=|±½〉, 
gx,y=2.55, gz=2.40, D≫gβBS (50 cm−1), E/D=0.28 and 
AyI=7/2(59Co)=8.3×10−3 cm−1] from simulation of the signal elicited by 
the addition of amastatin to VpAP (Figure 4). 
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Figure 1: EPR spectra of VpAP upon reaction with LLL 
Traces A–E show the experimental EPR signals (upper traces), and computer 
simulations thereof (lower traces), from resting [CoZn(VpAP)] (traces A), and VpAP 
upon reaction with LLL at 2 °C for 10 ms (traces B), 20 ms (traces C), 1 s (traces D) 
and 1 min (trace E). The experimental traces F and G were generated by difference 
and each is overlaid with a computer simulation; traces F are the LLL-axial EPR signal 
and traces G are the LLL-rhombic signal. The proportions of individual species, the 
resting, LLL-axial and LLL-rhombic, used for the simulations are indicated in Figure 3, 
and the spin Hamiltonian parameters for each are: resting, S=3/2, MS=|±½〉, 
gx,y=2.57, gz=2.24, D≫gβBS (50 cm−1), E/D=0.21 and AyI=7/2(59Co)=8.1×10−3 cm−1; 
LLL-axial, S=3/2, MS=|±½〉, gx,y=2.28, gz=2.20, D≫gβBS (50 cm−1) and E/D=0.05; 
LLL-rhombic, S=3/2, MS=|±½〉, gx,y=2.56, gz=2.50, D≫gβBS (50 cm−1), E/D=0.29 
and AyI=7/2(59Co)=8.4×10−3 cm−1. 
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Figure 2: 59Co hyperfine structure in the EPR spectra of VpAP upon reaction 
with LLL 
Expanded region of the EPR spectra of resting [CoZn(VpAP)] (traces A), and of VpAP 
upon reaction with LLL at 2 °C for 10 ms (traces B), 20 ms (traces C) and 1 s (traces 
D) and 1 min (traces E); the upper traces of A–F are the experimental data and the 
lower traces are computer simulations. Trace F are of the LLL-rhombic species. The 
proportions of individual species, the resting, LLL-axial and LLL-rhombic, used for the 
simulations are indicated in Figure 3, and the spin Hamiltonian parameters for each 
are given in the legend to Figure 1. 
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Figure 3: Quantitative analysis of the EPR spectra of VpAP upon reaction with 
LLL 
Fractional intensities of the three EPR-detected species, the resting (●), LLL-axial (■) 
and LLL-rhombic (▲), of VpAP at rest and upon reaction with LLL for 10 ms, 20 ms, 
1 s and 1 min. 
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Figure 4: EPR spectra of complexes of [CoZn(VpAP)] with LLL and amastatin 
Traces A and C are EPR spectra of the LLL-rhombic complex of [CoZn(VpAP)] with LLL 
(trace A) and of [CoZn(VpAP)] with amastatin (trace C). Traces B and D are computer 
simulations of A and C respectively. Trace B was generated using the spin Hamiltonian 
parameters S=3/2, MS=|±½〉, gx,y=2.56, gz=2.50, D≫gβBS (50 cm−1), E/D=0.29 and 
AyI=7/2(59Co)=8.4×10−3 cm−1. Parameters for trace D were S=3/2, MS=|±½〉, 
gx,y=2.55, gz=2.40, D≫gβBS (50 cm−1), E/D=0.28 and AyI=7/2(59Co)=8.3×10−3 cm−1. 
 
X-ray crystallography 
Crystals of VpAP soaked with LLL were hexagonal, with a space 
group of P6122, as with other crystals of VpAP, and with unit cell 
parameters closest to those of the VpAP–BuBA complex (Table 1). The 
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X-ray crystal structure of LLL-soaked VpAP was determined to a 
resolution of 2.0 Å (1 Å=0.1 nm) and the crystallographic data 
collection and refinement statistics are given in Table 1. The protein 
fold was found to be very similar to that of the native enzyme (PDB 
code 1AMP [28]) and Cα superimposition gave an RMSD (root mean 
square deviation) of 0.3 Å. Careful examination of omit maps and B-
factors suggested that the electron density may be best described as 
representing a mixture of species, including LLL and LL bound at the 
active site (Figure 5). Additional possible contributions may arise from 
binding of LL and leucine in the S1, S1′ and S2′ sites; leucine is a poor, 
purely competitive, inhibitor of VpAP, and LL is also an inhibitor of LLL 
hydrolysis, although the mechanism is less clear. The main indicator of 
the possibility of multiple species is the poor occupancy and/or high B-
factors for the side chains of Leu295 when refining assuming 100% LLL 
bound. Additional refinements were carried out with leucine, LL, LA 
(Leu-Ala) and LAL (Leu-Ala-Leu). In each case, the backbone structure 
and the positions of the atoms of the P1-leucine, that is bound to the 
active-site metals, are superimposable to well within the resolution of 
the structure. A detailed examination of the structure of VpAP–LLL 
revealed a number of very interesting features, some of which are 
paralleled in the structures of inhibited complexes of VpAP: (i) in a 
significant proportion of the sample, LLL is bound to both metal ions in 
the active site and is intact; similarly, intact LL is also observed bound 
in a manner entirely analogous to LLL (Figures 5 and and6);6); (ii) the 
N-terminal carbonyl appears to be trigonal planar (sp2) indicating that 
the LLL and LL complexes represent pre-transition state complexes; 
(iii) LLL is bound with the side chain of P1-leucine apparently cis to P1′-
leucine (P1 denotes the N-terminal residue and P1′, P2′…Pn′ denote 
subsequent residues of substrates; S1, S1′…Sn′ are the complementary 
enzyme subsites [52]); (iv) the N-terminal carbonyl of LLL (and LL) 
provides a μ-bridging oxygen atom that binds both metal ions, distinct 
from the terminal binding of the substrate analogue inhibitor BuBA 
(PDB code 1CP6 [29]) and from the more complex bridge found with 
the transition state analogue inhibitor LPA (PDB code 1FT7 [30]), but 
analogous to that seen with bestatin (PDB code 1TXR [31]); (v) the 
M2 Zn(II) ion is also bound to the P1 amide nitrogen atom, forming a 
ring structure that includes M2 and is similar to that observed with 
LPA; (vi) there is no evidence for a water- or hydroxy-derived oxygen 
bound to M1 or bridging M1 and M2; (vii) the side chain of Glu151, a 
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residue implicated in proton delivery [32], appears to be cis to that of 
Glu152, which provides an oxygen ligand to Zn1; (viii) there is a water 
molecule hydrogen-bonded to the Zn(II)-binding oxygen atom, OE1, of 
Glu152 [rO(water)−OE1(Glu152)=2.7 Å; rO(water)−Zn1=3.9 Å], analogous to that 
observed at 2.9 Å from Glu152 OE1 in the structure with bestatin. OE1 
of Glu151 is hydrogen-bonded (2.8 Å) to the amide group of the P1′-
leucine of LLL (or LL). It should be noted that, in the cases of P1-
leucine and P1′-leucine of LLL, and of Glu151 and Glu152 respectively, 
the apparent cis configuration of the side chains is not due to a cis 
peptide bond; this is evident in the case of LLL by examination along 
the peptide bond of the structure. Rather, rotation around the ψ1 
carbonyl-C–Cα bond of P1-leucine of LLL, and the analogous C–Cα ψ 
bond of Glu151, is responsible. Unlike in the case of a genuine cis pair, 
the appropriate residues fall into the additionally allowed category in 
the Ramachandran plot rather than the generously allowed category; 
we refer herein to such pairs of residues as adopting a ‘torqued-ψ’ 
configuration. Other features of this structure include the retention of 
the cis configuration, seen in the native structure, of Asp118 and the 
adjacent metal-bridging residue Asp117. Asp118 was one of two residues 
in the generously allowed region of the Ramachandran plot, the other 
being the substrate-binding hydrophobic pocket residue Met180. A 
water molecule is observed at 2.4 Å from the OD1 oxygen atom of 
Asp118. The final significant difference between the native and LLL-
bound structures is the conformation of the side chain of His105; in the 
VpAP–LLL complex, this appears to fold over to form a ‘cap’ over the 
side chain of the P2′-leucine of LLL, although no direct contact of His105 
to LLL is made. 
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Figure 5: Active-site structure of crystalline VpAP soaked in LLL 
Labels identify the two Zn(II) ions and the VpAP residues His97, Asp117, Glu151, Glu152, 
Asp179 and His256 of VpAP. The ligand is shown as an overlay of refined positions for 
leucine (black), LL (dark grey) and LLL (light grey) and the darkness reflects the 
occupancies. 
 
 
Figure 6: Schematic diagram of the active site in the VpAP–LLL complex 
Interatomic distances are shown in Å. 
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Parameter Value 
Unit cell parameters  
 a (Å) 108.4 
 b (Å) 108.4 
 c (Å) 96.8 
 α, β, γ (°) 90, 90, 120 
Collection and refinement parameters  
 Total number of reflections 524877 
 Unique reflections 23236 
 Space group P6122 
 Resolution range (Å) 50.0–2.0 
 Last shell (Å) 2.07–2.00 
 Rsym 0.087 
 Overall completeness (%) 96.2 
 Last shell completeness (%) 78.3 
 Rcryst 0.206 
 Rfree 0.247 
Ramachandran plot  
 Most favoured (%) 84.9 
 Additional allowed (%) 14.3 
 Generously allowed (%) 0.8 (Asp118, Met180) 
 <I/σI> 12.3 
Table 1: Unit cell, symmetry and refinement parameters from crystallo-
graphic analysis of the VpAP–LLL complex (PDB code 2IQ6) 
Discussion 
RFQ–EPR is one of the few techniques that allow interrogation of 
catalytic intermediates in enzymatic reactions. In the present study, 
two intermediates have been shown by RFQ–EPR to be catalytically 
competent and one, the LLL-rhombic species, has been well 
characterized in terms of detailed spin Hamiltonian parameters. These 
parameters indicate a high degree of electronic structural similarity to 
the inhibited complexes of VpAP with bestatin and amastatin; 
analogous structural elements for these species are predicted. In 
particular, from both the EPR parameters of the LLL-rhombic species 
itself and by analogy with the EPR and structures of the bestatin and 
amastatin complexes of VpAP, the LLL-rhombic species is likely to 
involve multiple ligands to the dinuclear metal centre, including a 
metal-bridging oxygen, and does not accommodate an M1-bound 
water/hydroxy nucleophile candidate. 
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The crystal structure of the VpAP–LLL complex is the first 
example of a structure of a leucine aminopeptidase complex with a 
bona fide substrate. This structure is highly analogous to that of the 
bestatin complex and the spectrokinetic RFQ–EPR data provide very 
strong evidence that the structure of the active site in the 
crystallographically characterized VpAP–LLL complex corresponds to 
the kinetically competent LLL-rhombic catalytic intermediate species in 
solution. Thus the crystallographic data provide high-resolution 
structural information on a species that has been determined to be a 
catalytically competent reaction intermediate in solution. 
The crystal structure of the VpAP–LLL complex is extremely 
interesting in a number of respects. Most strikingly, the structure 
shows that LLL, or its primary product LL, is bound at the active site 
forming a pre-transition state complex, but that there is no water or 
hydroxy group bound to Zn1. LLL/LL provides one ligand, the μ-
bridging carbonyl oxygen atom, to Zn1. Thus the co-ordination 
number of Zn1 in the VpAP–LLL complex and in the resting enzyme is 
the same. As the complex is a pre-transition state complex, formation 
of the transition state requires nucleophilic attack by a hydroxy group 
on the sp2-hybridized carbonyl carbon atom to form a tetrahedral 
intermediate. In the previously proposed mechanism [29,30], the 
nucleophilic hydroxy group was proposed to arise as a result of 
terminalization on to Zn1 of a hitherto μ-bridging water or hydroxy 
group. This Zn1-bound hydroxy group, activated by the Lewis acidity 
of the Zn(II) ion, was then proposed to attack the substrate, also 
bound to Zn1. However, whereas there is evidence in a related 
methionyl aminopeptidase for a metal ion bound simultaneously to a 
substrate analogue and a nucleophilic hydroxy group [53], there is no 
such evidence for VpAP. The structure of the VpAP complex with the 
substrate analogue BuBA shows that the oxygen that was presumed to 
be that of the active nucleophile is weakly associated with the boron 
atom of BuBA (rB−O=2.4 Å), but is completely dissociated from the 
Zn(II) ions. In other crystal structures of VpAP complexes, with 
bestatin and with LPA, there is also no M1-bound water molecule, but 
there is a water molecule hydrogen-bonded to OE2 of Glu152 in the LPA 
complex and to OE1 of Glu152 in the bestatin complex. The possible 
catalytic significance of this water molecule has been hitherto 
overlooked. The observation that there is no M1-bound water 
molecule, but that there is a water molecule hydrogen-bonded to 
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Glu152 OE1 in the VpAP–LLL complex, however, takes on mechanistic 
significance if this species corresponds to a kinetically competent 
catalytic intermediate in solution. The perhaps startling implication is 
that the nucleophilic hydroxy group is activated and delivered to the 
substrate not from the catalytically essential M1 metal ion, but from 
either Glu152 or Asp118. Glu152 is the most likely candidate, particularly 
given the inductive effect on Lewis acidity by virtue of also binding 
Zn(II), and initial work on site-directed variants has shown the 
catalytic importance of a carboxy-containing amino acid at position 
152; a fuller characterization of Glu152 and Asp118 substitution variants 
is warranted. The delivery of the nucleophile by a carboxy group is a 
mechanistic aspect that is analogous to nucleophile activation by 
aspartate carboxy side chains in the aspartic proteases. A recent 
computational study led Guo and co-workers to propose that the 
nucleophile is not delivered by the metal ion in the class B2 metallo-β-
lactamases, but, rather, by an aspartate residue [39]; this mechanism 
has distinct energetic benefits, and roles of the metal ion include 
electrophilic activation of substrate and stabilization of the leaving 
group. Activation of substrate by active-site metal ions, rather than 
nucleophile delivery, is a feature of the mechanism of class II 
aldolases [54]. 
The proposal that the active nucleophile in VpAP-catalysed 
hydrolysis is delivered not by a metal ion but by an active-site amino 
acid is supported by a wealth of circumstantial evidence. A number of 
observations are not well explained by the earlier proposed 
mechanism, but are much more consistent with the new one. First, 
VpAP exhibits substrate and reaction specificity, yet the active site is 
very exposed to the solvent. Active sites of the type found in VpAP are 
widely distributed among metallohydrolases, and a role in activating a 
nucleophilic hydroxy group would be unlikely to confer either reaction 
or substrate specificity. In VpAP, there is a hydrophobic patch adjacent 
to the active site and this probably plays a role in substrate recognition 
and specificity. However, with an exposed active site and an adjacent 
extended hydrophobic patch, it would be expected that VpAP would 
exhibit more stringent substrate specificity for larger substrates. In 
fact, precisely the opposite is observed. The substrate specificity of 
VpAP is most stringent for amino acid amides and amino acid p-
nitroanilides, efficiently hydrolysing only the leucine, isoleucine, valine, 
methionine and phenylalanine derivatives. Substrate specificity is 
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progressively less stringent for dipeptides and tripeptides, and only N-
terminal aspartate, glutamate or cysteine are absolutely resistant to 
hydrolysis in some larger peptides [36,37]. The key to understanding 
the substrate specificity may be in appreciating the significance of the 
finding that the P1- and P1′-leucine residues in the VpAP–LLL complex 
are in a torqued-ψ configuration. This configuration is stabilized by the 
interaction of the P1-leucine amino nitrogen with Zn2, and the 
proximity of the P1 and P1′ side chains results in sterically induced 
strain in the peptide bond. The relevance of this to catalysis is 
highlighted by the high enthalpy of hydrolysis by VpAP, indicative of 
conformational change. It is proposed here that the role of the metal 
ions is therefore to act in concert with the hydrophobic patch to induce 
the P1-P1′ torqued-ψ conformation change and stabilize the consequent 
pre-transition state complex, weakening the scissile bond for 
hydrolysis. Furthermore, binding to the metal ions electrophilically 
activates the carbonyl carbon atom for nucleophilic attack. A torqued-
ψ conformation is of little consequence for amino acid amides and p-
nitroanilides, and only the most favourable bulky hydrophobic 
substrates are hydrolysed efficiently. Dipeptides are the smallest 
substrates that can be geometrically activated via an enzyme-induced 
torqued-ψ conformation. This higher energy conformation can be 
stabilized further by interaction of larger substrates with the 
hydrophobic patch, particularly those with hydrophobic P1′, P2′ etc. 
residues; the phenomenon is reflected in the more efficient and less N-
terminal-specific hydrolysis of peptides with hydrophobic P1′, P2′ and 
P3′ residues [35,37]. 
Other observations perhaps further the contention that the role 
of the metal centre, and M1 in particular, is not to activate and deliver 
the nucleophile to the substrate. First, the pH-dependence of kcat 
indicated that the free base form of an enzyme functional group with 
pKa of ∼5.3 is required for hydrolysis of bound substrate [55]. This 
suggests that the nucleophile is either derived from an aspartyl or 
glutamyl carboxy group; more specifically, work on thermolysin has 
suggested a concerted ‘inductive’ effect of a Glu-COO−-H2O-Zn(II) 
structure in deprotonation of the carboxylate hydroxy group [56] and 
therefore supports the hypothesis that the nucleophile is bound to the 
same carboxy group oxygen, OE1 of Glu152, that is bound to Zn1 in the 
VpAP–LLL complex. A second observation on VpAP that is not well-
explained by the earlier proposed mechanism is the complex pattern of 
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activation of apoVpAP by transition metal ions. VpAP can be activated 
with Zn(II), Co(II), Ni(II) and Cu(II), and the degree of activation of 
the enzyme is dependent both upon the chemical identity of the metal 
ions added and their order of addition, but not with Fe(II) or Mn(II) 
[26,38]. The activation observed is not predictable on the basis of the 
Lewis acidity of M1. For instance, [ZnCu(VpAP)] is as active as the 
monometallic [Zn_(VpAP)] and is 80% as active as the homodimetallic 
[ZnZn(VpAP)], whereas [Cu_(VpAP)] and [CuCu(VpAP)] are 5–6-fold 
more active than [ZnZn(VpAP)]; [CuZn(VpAP)], on the other hand, is 
two orders of magnitude more active than [ZnZn(VpAP)], and Ni(II) 
elicits an activation profile analogous to that of Cu(II). The ability of 
Cu(II) at the M1 site to activate VpAP, but not the related methionyl 
aminopeptidase has been proposed to indicate that specificity is 
dependent upon the co-ordination geometry of the M1 ion rather than 
Lewis acidity [57]. The pronounced hyperactivity of [CuZn(VpAP)] over 
[CuCu(VpAP)] indicated that the precise structure of the dinuclear site 
is important; Cu2 in [CuCu(VpAP)] is not bound in the same site as Zn 
in [CuZn(VpAP)]. The apparent requirement for nucleophile activation 
with a pKa of ∼5.3 and the sensitivity of VpAP activity to the active-site 
geometry are entirely consistent with a Glu152-derived nucleophile and 
a role for the metal ions in substrate binding and activation rather than 
of nucleophile activation. The torqued-ψ arrangement of Glu151 and 
Glu152, and the role of Glu151 in proton transfer to the substrate [32], 
provide further circumstantial support for the role of Glu152. The 
observation that Asp117 and Asp118, and Glu151 and Glu152, are in cis and 
torqued-ψ configurations respectively, was made in the original report 
of the crystal structure of VpAP, and the general phenomenon that 
non-proline cis amino acid pairs are generally involved in catalysis was 
noted and discussed [28]. 
The new proposal, that the nucleophile in VpAP-catalysed 
hydrolysis is not delivered by the metal ion, is consistent with all the 
earlier reported data on VpAP and with the crystal structure described 
herein, and it better explains other phenomena observed with VpAP. 
This circumstantial evidence supports the new mechanism and 
therefore the contention that the crystallographically characterized 
active site in the VpAP–LLL complex corresponds to a genuine catalytic 
intermediate. Experimental evidence for this contention is, however, 
very desirable and would considerably strengthen the case for the new 
mechanism. EPR studies supply this crucial evidence. Co(II) in the M1 
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position of [CoZn(VpAP)] exhibits a rhombic EPR signal with resolved 
hyperfine structure and, along with electronic absorption 
spectrophotometry, these data indicate a five-co-ordinate site with a 
relatively constrained and distorted geometry that includes a μ-
bridging hydroxy group as a ligand to Co(II) [1,25,26]. Upon reaction 
of [CoZn(VpAP)] with LLL under reaction conditions where the turnover 
time is 380 ms, two new EPR species are detected, with significant 
yields, within 10 ms. The first, the LLL-axial species, is indicative of a 
six-co-ordinate Co(II) species with axial electronic symmetry and a 
free water or hydroxy group ligand that is responsible for the 
microheterogeneous structure of the Co(II) ions, reflected in the very 
broad EPR signal [1]. This species accounts for approx. 10% of the 
enzyme molecules and rapidly diminishes thereafter; it is therefore 
short-lived. The second species, the LLL-rhombic species, is a five-co-
ordinate species that is clearly distinct, both by observation and from 
the spin Hamiltonian parameters, from the resting species. The very 
narrow linewidths indicate that the co-ordination sphere consists of 
‘rigid’ ligands with very little geometrical heterogeneity among the 
population and argues strongly against co-ordinated water or hydroxy 
group. Furthermore, this signal is very similar to the signals elicited by 
amastatin and bestatin. The LLL-rhombic species accounts for 23% of 
the enzyme molecules during the pre-steady-state phase of the first 
turnover and diminishes to 11% by the third turnover. The high pre-
steady-state concentrations of this species and the lower 
concentrations as conditions approach the steady state are 
characteristic of a relatively long-lived, but nevertheless catalytically 
competent, intermediate that is formed after the LLL-axial species. 
Thus EPR indicates that, upon reaction of the five-co-ordinate, hydroxy 
group-bearing Co(II) ion in [CoZn(VpAP)] with LLL, the six-co-ordinate 
LLL-axial species, bearing an unconstrained water or hydroxy group, is 
first formed. This is presumably due to substrate binding via the 
carbonyl oxygen. However, rather than this step being followed by 
nucleophilic attack, a subsequent five-co-ordinate intermediate species 
devoid of a free water/hydroxy group ligand, the LLL-rhombic, is 
formed instead. Thus, consistent with the new mechanism, RFQ–EPR 
identifies two kinetically competent catalytic intermediates: the first 
formed by addition of substrate and the second by subsequent 
dissociation of a water or hydroxy group. 
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A central question is whether either of the EPR-identified 
intermediates correspond to the crystallographically characterized 
active site in VpAP–LLL. The structure of the bestatin and amastatin 
complexes of VpAP is well-characterized, and the active site in these 
complexes is very similar indeed to that of the VpAP–LLL complex 
described herein, including a ligand carbonyl-derived μ-oxygen bridge, 
an LLL-derived ring structure based on M2, the lack of an M1-bound 
candidate for the nucleophile and the presence of a water molecule 
hydrogen-bonded to OE1 of Glu152. It is therefore most striking that 
this structural similarity is paralleled by the congruency of the EPR 
signals of the bestatin and amastatin species with that of the LLL-
rhombic signal observed in RFQ–EPR experiments on VpAP with LLL. It 
is also remarkable that the details of the EPR spectrum of the LLL-
rhombic species are entirely consistent with the structure of the VpAP–
LLL complex. The likely conclusion, then, is that the 
crystallographically characterized active site of VpAP–LLL corresponds 
to a kinetically competent catalytic intermediate, the LLL-rhombic 
species, of the reaction of VpAP with LLL. These data provide very solid 
support for the newly proposed mechanism. 
A final phenomenon worthy of discussion is the low catalytic 
activity of crystalline VpAP towards LLL. The crystallographic data 
suggest that some activity had occurred, as LL is seen binding as a 
substrate in an analogous manner to LLL. Furthermore, it is likely that 
LL was partially hydrolysed and a number of species in which leucine is 
bound to VpAP may be present. It is noteworthy that leucine is a pure 
competitive inhibitor of VpAP and that, even at very high 
concentrations, does not bind to Co(II) in cobalt-substituted VpAP. 
Nevertheless, the high concentrations of leucine and LL may have 
contributed to the poor activity of VpAP towards LLL, perhaps via an 
entropic mechanism. Another possible reason for the low activity of 
crystalline VpAP towards LLL (and LL) is that a conformational change 
is required, as indicated by thermodynamic analyses, that is inhibited 
in the crystalline state. The change in crystal appearance upon soaking 
with LLL and the increased fragility of the crystals may suggest this. As 
the protein fold is identical in VpAP–LLL and native (or Tris-complexed) 
VpAP, this may suggest that a conformational change occurs after 
substrate binding and reorientation. A second possibility is that while 
the active site of VpAP–LLL corresponds to that in the reaction 
intermediate, the protein fold differs in solution from that in the 
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crystal. Finally, the altered conformation of the side-chain His105 may 
or may not be significant. EPR spin-labelling experiments are 
underway to address some of these issues. 
In summary, very strong evidence is presented that the active 
nucleophile in VpAP catalysis is not delivered by the metal centre. The 
most likely candidate for the nucleophile is a water molecule 
hydrogen-bonded to a carboxylate oxygen atom, itself a ligand to a 
Zn(II) ion, of an active-site glutamate residue, Glu152. These findings 
prompt a theoretical revisiting of the mechanisms of metallohydrolases 
and have significant consequences for rational design of 
therapeutically important inhibitors of these enzymes. 
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